Role of Low-Level Laser Therapy as an Adjunct in the Management of Diabetic Ulcer

Shijina Koliyath, Ravi K. Chittoria*, Chirra L. Reddy, Padmalakshmi B. Mohan, Imran Pathan, Neljo Thomas and Nishad Kerakada

Role of Low-Level Laser Therapy as an Adjunct in the Management of Diabetic Ulcer.

Diabetes mellitus is a chronic debilitating condition affecting people worldwide and diabetic foot ulcers are also a common problem. The treatment of diabetic ulcers requires a multimodal approach. Adjuvant low-level laser therapy may be useful in lesions with protracted healing course but the evidence is still limited.

In this study, we share our experience regarding the use of low-level laser therapy as an adjuvant treatment modality in a patient with diabetic foot ulcer. Diabetic foot ulcers cause morbidity and frequent visit to healthcare professionals and may lead to lower extremity amputation.

A multimodality approach is recommended to address potential underlying problems. Proper clinical examination and shoe gear, gait, orthopedic, neurologic, and vascular examination are also recommended. Appropriate offloading and continuing diabetes education are also an important aspect included in the treatment for all DFUs.

Various treatment options are available. The study was a 70-yearold male with known case of hypertension, diabetes mellitus and dyslipidemia. The patient had a non-healing ulcer at the first web space of left foot for 3-months. Wound bed preparation.
Laser therapy is painless, cost effective procedure which induces faster granulation, wound contraction and re-epithelialization, thus accelerates complete wound healing hence avoiding secondary procedures like split skin grafting in many cases.

Control of infection is also better in patients whom low-level laser therapy
was given.16 In addition to reducing the lesion area and accelerating the healing process, laser therapy has the advantage of being easily administered. These benefits assist in promoting patient quality of
life and minimizing possible complications.

Clin Trial Pract Open J. 2020; 3(1): 26-28. doi: 10.17140/CTPOJ-3-116